XML 81 R64.htm IDEA: XBRL DOCUMENT v3.24.1
Schedule of Restricted Stock Award Activity (Details) - Restricted Stock [Member] - $ / shares
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]    
Number of Restricted Stock Awards, Outstanding Ending 2,091,420 1,940,740 [1]
Weighted Average Grant Date Fair Value, Outstanding Ending $ 11.44 $ 12.76 [1]
Number of Restricted Stock Awards, Granted 550,000 320,000
Weighted Average Grant Date Fair Value, Granted $ 1.29 $ 4.53
Number of Restricted Stock Awards, Vested (303,980) (169,320)
Weighted Average Grant Date Fair Value, Vested $ 11.95 $ 13.48
Number of Restricted Stock Awards, Forfeited
Weighted Average Grant Date Fair Value, Forfeited
Number of Restricted Stock Awards, Outstanding Ending 2,337,440 2,091,420
Weighted Average Grant Date Fair Value, Outstanding Ending $ 8.99 $ 11.44
[1] The unvested restricted stock awards presented in the table above, are inclusive of 50,000 restricted stock awards granted outside the Lucid Diagnostics 2018 Equity Plan as of December 31, 2022. These 50,000 restricted stock awards were fully vested during the year ended December 31, 2023.